Accu-Chek Guide and Accu-Chek Performa blood glucose meters 14 November 2019 Product defect correction – risk of delayed therapy due to potential battery issues Consumers and healthcare professionals are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters. Accu-Chek Guide and Accu-Chek Performa blood glucose meters are used by people with diabetes to monitor their blood glucose (also known as blood sugar) levels. These meters are supplied individually and also in a meter kit. Please visit www.accu-chek.com.au for more information. The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
Media releases 20 July 2024 Expert modelling shows huge cost savings for diabetes technology New research shows continuous glucose monitoring devices can dramatically reduce the risk of life-threatening diabetes-related complications including blindness, cardiovascular disease... Continue Reading
Media releases 18 July 2024 Uniting for technology access for Aboriginal and Torres Strait Islander people Diabetes Australia is calling on the government to support access to life-changing diabetes technology for Aboriginal and Torres Strait Islander... Continue Reading
Blog 18 July 2024 Cheryl’s story Cheryl’s journey with type 2 diabetes began 15 years ago when she was diagnosed unexpectedly during a routine blood test. “It turned my world upside down." Continue Reading